CLINICAL_TRIALS ClinicalTrials.gov record with results posted

Early GLP-1 Receptor Agonist and SGLT2 Inhibitor Add-On Strategies in Adults With Obesity, Type 2 Diabetes, Cardiovascular-Kidney-Metabolic Syndrome Stage 2-3, and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Target Trial Emulation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT07566299
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-06-26T00:07:40.090793+00:00
Published At: 2026-06-25T00:00:00+00:00
Record Updated At: 2026-06-25
Results Posted At: 2026-06-25
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Obesity Type 2 Diabetes Mellitus", "Cardiovascular-kidney-metabolic Syndrome", "Metabolic Dysfunction-Associated Steatotic Liver Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-06-25"
protocolSection.identificationModule.nctId: "NCT07566299"
protocolSection.identificationModule.officialTitle: "Early GLP-1 Receptor Agonist and SGLT2 Inhibitor Add-On Strategies in Adults With Obesity, Type 2 Diabetes, Cardiovascular-Kidney-Metabolic Syndrome Stage 2-3, and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Target Trial Emulation"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-06-25"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.